COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients - Université de Nîmes Accéder directement au contenu
Pré-Publication, Document De Travail Année : 2020

COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients

Christian Siatka
  • Fonction : Auteur
  • PersonId : 1068312
Jun Nishimura
  • Fonction : Auteur
Christophe Duroux
  • Fonction : Auteur
George Ferrandi
  • Fonction : Auteur

Résumé

This global epidemic of coronavirus that we are currently experiencing, need an over view on the biological markers that allow the monitoring of COVID-19 disease. After a synopsis of the clinical characteristics and the management of patients, we propose a literature review of the diagnostic tests which include molecular and serological diagnosis. The aim of this document is to show the biological markers involved in screening, triage and prognosis, which involves white blood cells, platelets, Ddimer, CRP and fibrinogen. While acknowledging that these parameters are not exhaustive, they nonetheless represent essential biological markers for the management of this epidemic

Mots clés

Fichier principal
Vignette du fichier
COVID-19 Article HORIBA.pdf (642.02 Ko) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)
Loading...

Dates et versions

hal-02547315 , version 1 (19-04-2020)

Licence

Paternité - Pas d'utilisation commerciale - Pas de modification

Identifiants

  • HAL Id : hal-02547315 , version 1

Citer

Christian Siatka, Marion Eveillard, Jun Nishimura, Christophe Duroux, George Ferrandi. COVID-19 screening, prognosis and severity assessment with biomarkers for management of patients. 2020. ⟨hal-02547315⟩

Collections

UNIMES
405 Consultations
311 Téléchargements

Partager

Gmail Facebook X LinkedIn More